Breaking News

Aterian Investment Partners Acquires CPL

CPL represents Aterian’s thirteenth investment in the life sciences.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Aterian Investment Partners, a private investment firm, announced that one of its affiliates has closed its acquisition of Contract Pharmaceuticals Ltd. Canada, a North American contract development and manufacturing organization (CDMO) of non-sterile liquid and semi-solid dosage forms.   Based in Mississauga, ON, CPL has longstanding relationships with 15 of the top 20 global pharmaceutical companies. CPL supports customers through its FDA and Health Canada-registered facilities and sells int...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters